首页> 外文OA文献 >MA11.05 A Case-Control Study to Test the Use of ctDNA in the Early Detection of SCLC Reveals TP53 Mutations in Non-Cancer Controls

【2h】

MA11.05 A Case-Control Study to Test the Use of ctDNA in the Early Detection of SCLC Reveals TP53 Mutations in Non-Cancer Controls

机译：MA11.05一种案例对照研究，用于测试CTDNA在早期检测SCLC中的使用揭示了非癌症对照中的TP53突变

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Lynnette Fernandez-Cuesta; Sandra Perdomo; Patrice Avogbe; Noémie Leblay; Tiffany Delhomme; Valerie Gaborieau; Behnoush Abedi-Ardekani; Estelle Chanudet; Magali Olivier; David Zaridze; Anush Mukeria; Marta Vilensky; Ivana Holcatova; Jerry Polesel; Lorenzo Simonato; Cristina Canova; Pagona Lagiou; Christian Brambilla; Elisabeth Brambilla; Graham Byrnes; Ghislaine Scelo; Florence Le Calvez-Kelm; Matthieu Foll; James Mckay; Paul Brennan;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. MA11.05 A Case-Control Study to Test the Use of ctDNA in the Early Detection of SCLC Reveals TP53 Mutations in Non-Cancer Controls [J] . Lynnette Fernandez-Cuesta, Sandra Perdomo, Patrice Avogbe, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：MA11.05一种案例对照研究，用于测试CTDNA在早期检测SCLC中的使用揭示了非癌症对照中的TP53突变
2. MA11.05 A Case-Control Study to Test the Use of ctDNA in the Early Detection of SCLC Reveals TP53 Mutations in Non-Cancer Controls [J] . Lynnette Fernandez-Cuesta, Sandra Perdomo, Patrice Avogbe, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：MA11.05一种案例对照研究，用于测试CTDNA在早期检测SCLC中的使用揭示了非癌症对照中的TP53突变
3. Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib [J] . Chiara Dalle Fratte, Michela Guardascione, Elena De Mattia, Frontiers in Pharmacology . 2020,第4期

机译：克隆在胰岛素/ PDGFRA野生型胃肠基质肿瘤CTDNA中发现的一种新型有害TP53体细胞突变，耐用于伊马替尼
4. DETECTION OF A CLINICALLY RELEVANT TP53 GENE MUTATION USING DNA LABEL-FREE BIOSENSORS [C] . D. DELLATTI, M. MINUNNI, S. TOMBELLI, Italian Conference on Sensors and Microsystems . 2008

机译：使用DNA标记的生物传感器检测临床相关的TP53基因突变
5. Association of estrogen metabolism and risk of breast or prostate cancer or non-Hodgkin lymphoma: Detection of novel biomarkers from case-control studies. [D] . Yang, Li. 2010

机译：雌激素代谢与乳腺癌或前列腺癌或非霍奇金淋巴瘤风险的关联：病例对照研究中发现的新型生物标志物。
6. Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib [O] . Chiara Dalle Fratte, Michela Guardascione, Elena De Mattia, 2020

机译：在抗伊马替尼的KIT / PDGFRA野生型胃肠道间质瘤ctDNA中发现新型有害TP53体细胞突变的克隆选择
7. MA 06.09 Detection of EGFR T790M Mutations by Four Testing Platforms in ctDNA from Chinese Patients with Advanced NSCLC [O] . X. Zhang, Z. Liang, Y. Chen, 2017

机译：MA 06.09中国高级NSCLC患者CTDNA中的四个测试平台检测EGFR T790M突变

MA11.05 A Case-Control Study to Test the Use of ctDNA in the Early Detection of SCLC Reveals TP53 Mutations in Non-Cancer Controls

著录项

相似文献

相关主题

期刊订阅